已收盤 05-08 16:00:00 美东时间
+0.390
+0.79%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
TD Cowen analyst Dan Brennan maintains Tempus AI (NASDAQ:TEM) with a Buy and raises the price target from $65 to $68.
05-07 02:28
Tempus AI (TEM) Q1 results: Revenue up 36.1% to $348.1M, beating estimates. TEM raises 2026 outlook amid strong AI & diagnostic demand.
05-06 18:12
华盛资讯5月6日讯,Tempus Al公布2026财年Q1业绩,公司Q1营收3.48亿美元,同比增长36.1%,归母净利润亏损1.26亿美元,同比亏损扩大85.1%。
05-06 10:34
Tempus AI shares are trading lower, The company reported Q1 financial results.
05-06 05:06
华盛资讯5月6日讯,Tempus Al公布2026财年Q1业绩,公司Q1营收3.48亿美元,同比增长36.1%,归母净利润亏损1.26亿美元,同比亏损扩大85.1%。
05-06 07:32
Tempus AI (NASDAQ:TEM) raises FY2026 sales outlook from $1.590 billion to $1.590 billion-$1.600 billion vs $1.592 billion estimate.
05-06 04:04
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
https://www.wsj.com/pro/venture-capital/fda-turns-to-ai-to-speed-up-clinical-trials-c10d1d
04-29 01:24
Large-cap stocks surged last week as catalysts from short squeezes to innovation-driven momentum fueled broad gains.
04-19 22:01